Patient-facing clinical trial software company uMotif has raised $3.2 million (£2.4 million) in a new funding round led by independent investment manager Albion Capital, with additional participation from unnamed angel investors.
uMotif makes apps for capturing consent, electronic patient-reported outcomes (ePRO), and electronic clinical outcome assessment (eCOA). The UK-based company, founded in...
